Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2025-12-27 @ 4:32 AM
Study NCT ID:
NCT05360368
Status:
UNKNOWN
Last Update Posted:
2022-05-05
First Post:
2022-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-26
First Submit QC Date:
None
Study First Post Date:
2022-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-03
Last Update Post Date:
2022-05-05
Last Update Post Date Type:
ACTUAL